Why is Kwality Pharma falling/rising?

As of 22-Sep, Kwality Pharmaceuticals Ltd is currently priced at 944.90, reflecting a decrease of 12.95 points or 1.35%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 4.24%. Today's trading saw the stock reach an intraday high of Rs 979.85 and a low of Rs 932.4, indicating volatility within the session. Despite this decline, the company has demonstrated strong fundamentals, including a low Debt to EBITDA ratio of 1.03 times and positive financial results over the last six quarters, which may support its valuation. The stock has generated a return of 19.01% over the past year, significantly outperforming the broader market, which has seen negative returns.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has gained 0.46% over the past week, while Kwality Pharmaceuticals has declined by 2.59% in the same period. This underperformance highlights a divergence from market trends, despite the company's strong historical returns and attractive valuation metrics. The stock's liquidity remains adequate for trading, and increased investor participation suggests ongoing interest, even as it faces short-term price pressures. Overall, while the stock has shown resilience in the long term, its recent price movement reflects a combination of market dynamics and investor sentiment.